Mutations in the mitochondrial gene were recently identified in a large pedigree of diabetes mellitus and deafness. As the
mitochondrial gene is maternally inherited, Japanese diabetic patients whose mothers were also diabetic were screened, using
peripheral leucocytes, for an A to G transition at nucleotide pair 3243 of the mitochondrial gene, a tRNA
Leu(UUR) mutation. This mutation was identified in four pedigrees from among 300 unrelated patients who were screened. Diabetes co-segregated
with the mutation, except in one young subject, and was maternally inherited. The apparent onset of disease occurred between
11 and 68 years of age. Some of the affected members developed hearing impairment and congestive heart failure due to cardiomyopathy,
though generally long after the onset of diabetes, and these patients had therefore not been diagnosed as having a specific
form of diabetes. The duration of sulphonyl-urea treatment was not more than 8 years in these pedigrees and affected members
were prone to progression to insulin-requiring diabetes. Thus, these patients were secondary sulphonylurea failures. Long-term
follow-up revealed that the underlying disorder in affected members is a progressive impairment of insulin secretion. Some
were initially diagnosed as having IDDM based on an apparent acute onset in youth and the clinical severity of their diabetes.
Others were regarded as having MODY with an aggressive course. The mitochondrial gene mutation or diabetes is not transmitted
to all offspring of the affected mothers. In conclusion, a mitochondrial tRNA
Leu(UUR) gene mutation accounts for slightly more than 1 % of diabetic patients with maternally inherited disease and manifests a
wide range of diabetic phenotypes, from the NIDDM phenotype to IDDM, in Japanese.
Key words Insulin secretion impairment - secondary sulphonylurea failure - mitochondria - maternal inheritance